Yue P, Zhu Y, Brotherton-Pleiss C, Fu W, et al. Novel potent azetidine-based compounds irreversibly inhibit Stat3 activation and induce antitumor response against human breast tumor growth in vivo. Cancer Lett 2022;534:215613.
PMID: 35276290